331 related articles for article (PubMed ID: 6782183)
1. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
Rijken DC; Wijngaards G; Welbergen J
J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
[TBL] [Abstract][Full Text] [Related]
2. Immunological characterization of plasminogen activators in human mixed saliva.
Kjaeldgaard A; Kjaeldgaard M
Acta Physiol Scand; 1986 Mar; 126(3):443-7. PubMed ID: 3515850
[TBL] [Abstract][Full Text] [Related]
3. Separation of plasminogen activators from human plasma and a comparison with activators from human uterine tissue and urine.
Kok P
Thromb Haemost; 1979 Jun; 41(4):734-44. PubMed ID: 483246
[TBL] [Abstract][Full Text] [Related]
4. Separation of plasminogen activators from human uterine tissue and a comparison with activators from human urine and porcine tissue.
Kok P
Thromb Haemost; 1979 Jun; 41(4):718-33. PubMed ID: 113901
[TBL] [Abstract][Full Text] [Related]
5. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
Wijngaards G
Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
7. Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid.
Casslén B; Thorell J; Astedt B
Contraception; 1981 Apr; 23(4):435-45. PubMed ID: 7023822
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.
Kirchheimer JC; Pflüger H; Ritschl P; Hienert G; Binder BR
Invasion Metastasis; 1985; 5(6):344-55. PubMed ID: 4066206
[TBL] [Abstract][Full Text] [Related]
9. Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase.
Holmberg L; Kristoffersson AC; Lecander I; Wallén P; Astedt B
Scand J Clin Lab Invest; 1982 Jun; 42(4):347-54. PubMed ID: 6753100
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues.
Camiolo SM; Markus G; Englander LS; Siuta MR; Hobika GH; Kohga S
Cancer Res; 1984 Jan; 44(1):311-8. PubMed ID: 6197164
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activators in human malignant melanoma.
Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
13. Isolation and purification of plasminogen activator from Yoshida ascites Sarcoma of rats.
Nulkar MW; Pawse AR
Indian J Biochem Biophys; 1991 Feb; 28(1):46-51. PubMed ID: 1905268
[TBL] [Abstract][Full Text] [Related]
14. [Isolation and characteristics of urokinase-type plasminogen activator from a culture of human embryo lung fibroblasts].
Shevelev AIa; Barshevskaia TN; Belogurov AA; Kratasiuk GA; Goriunova LE
Mol Biol (Mosk); 1986; 20(3):778-88. PubMed ID: 3088432
[TBL] [Abstract][Full Text] [Related]
15. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining.
Kohga S; Harvey SR; Weaver RM; Markus G
Cancer Res; 1985 Apr; 45(4):1787-96. PubMed ID: 3884145
[TBL] [Abstract][Full Text] [Related]
16. Immunological analysis of plasminogen activators from cultured human cancer cells.
Naito S; Sueishi K; Hattori F; Tanaka K
Virchows Arch A Pathol Anat Histol; 1980; 387(3):251-7. PubMed ID: 6779412
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activators in human xenografted oro-pharyngeal squamous cell carcinomas.
Björlin G; Ljungnér H; Wennerberg J; Astedt B
Acta Otolaryngol; 1987; 104(5-6):568-72. PubMed ID: 3434279
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
Bykowska K; Rijken DC; Collen D
Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification.
Corasanti JG; Celik C; Camiolo SM; Mittelman A; Evers JL; Barbasch A; Hobika GH; Markus G
J Natl Cancer Inst; 1980 Aug; 65(2):345-51. PubMed ID: 6931252
[TBL] [Abstract][Full Text] [Related]
20. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]